Endoscopic stenting of the common bile duct allows successful treatment of a breast cancer patient with excessive liver metastases.
The treatment of a jaundiced patient with hyperbilirubinaemia due to breast cancer liver metastases is still a challenging problem. The associated hepatic dysfunction often represents a limiting factor for delivering standard dose chemotherapy. We report on the successful treatment of a jaundiced patient with excessive, recurrent liver metastases from breast cancer, using a combined chemotherapy of mitomycin and 5-fluorouracil after endoscopic stenting of the common bile duct.
Eichbaum
Michael H R
MH
Department of Gynecology and Obstetrics, University of Heidelberg Medical School, Heidelberg, Germany. Michael_Eichbaum@med.uni-heidelberg.de
Schneeweiss
Andreas
A
de Rossi
Thomas
T
Bastert
Gunter
G
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology*; D003131:Combined Modality Therapy; D003135:Common Bile Duct / Q000473:pathology / Q000601:surgery; D003251:Constriction, Pathologic / Q000601:surgery; D004724:Endoscopy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology / Q000601:surgery; D008113:Liver Neoplasms / Q000150:complications / Q000556:secondary* / Q000628:therapy*; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D010166:Palliative Care; D015607:Stents
D016685:Mitomycin; D005472:Fluorouracil